BINDING OF TISSUE FACTOR PATHWAY INHIBITOR TO CULTURED ENDOTHELIAL CELLS-INFLUENCE OF GLYCOSAMINOGLYCANS - VII: Additional pathway initiating blood coagulation

Author： Iversen N.   Sandset P.M.   Abildgaard U.   Torjesen P.A.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.84, Iss.4, 1996-11, pp. : 267-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor

By Bladbjerg E.M.  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3235-3241

Oxford University Press

Access to resources Recommend Favorite

Factor VII, Tissue Factor Pathway Inhibitor, and Monocyte Tissue Factor in Diabetes Mellitus: Influence of Type of Diabetes, Obesity Index, and Age

By Vambergue A.   Rugeri L.   Gaveriaux V.   Devos P.   Martin A.   Fermon C.   Fontaine P.   Jude B.  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 367-375

Elsevier

Access to resources Recommend Favorite

Inhibition of the Tissue Factor Coagulation Pathway

By  

Current Vascular Pharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 319-327

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

Tissue Factor Pathway Inhibitor Endocytosis

By Schwartz A.L.   Broze G.J.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 7, 1997-10 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite